Ilya M. Rachman - 15 Dec 2021 Form 3 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CEO and Chairman, Director
Signature
/s/ Ilya Rachman
Issuer symbol
IMMX
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
3
Filing time
15 Dec 2021, 20:05:39 UTC
Next filing
20 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common stock 900,000 15 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IMMX Options (right to purchase) 15 Dec 2021 Common stock 270,000 $1.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 18, 2021, the Registrant issued the Reporting Person options to purchase up to 270,000 shares of the Registrant's common stock (the "Options"). The Options vest in 48 monthly installments with the first installment vesting on June 18, 2021.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney